Literature DB >> 24217999

Acetyl-L-carnitine and prevention of chemotherapy-induced peripheral neuropathy: can anything work?

Mauricio Burotto1, Antonio Tito Fojo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24217999      PMCID： PMC3825297          DOI： 10.1634/theoncologist.2013-0385

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  8 in total

Review 1.  Grading of chemotherapy-induced peripheral neuropathy.

Authors:  T J Postma; J J Heimans
Journal:  Ann Oncol       Date:  2000-05       Impact factor: 32.976

Review 2.  Bone-marrow haematopoietic-stem-cell niches.

Authors:  Anne Wilson; Andreas Trumpp
Journal:  Nat Rev Immunol       Date:  2006-02       Impact factor: 53.106

3.  Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.

Authors:  Ellen M Lavoie Smith; Herbert Pang; Constance Cirrincione; Stewart Fleishman; Electra D Paskett; Tim Ahles; Linda R Bressler; Camilo E Fadul; Chetaye Knox; Nguyet Le-Lindqwister; Paul B Gilman; Charles L Shapiro
Journal:  JAMA       Date:  2013-04-03       Impact factor: 56.272

4.  Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine.

Authors:  Giulia Bianchi; Giordano Vitali; Augusto Caraceni; Sabrina Ravaglia; Giuseppe Capri; Sante Cundari; Claudio Zanna; Luca Gianni
Journal:  Eur J Cancer       Date:  2005-08       Impact factor: 9.162

5.  Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells.

Authors:  Hai Wei Jin; Sarah J L Flatters; Wen Hua Xiao; Howard L Mulhern; Gary J Bennett
Journal:  Exp Neurol       Date:  2007-11-17       Impact factor: 5.330

Review 6.  Management of chemotherapy-induced nausea and vomiting : focus on newer agents and new uses for older agents.

Authors:  Rudolph M Navari
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546

7.  A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy.

Authors:  Mario Campone; Dominique Berton-Rigaud; Florence Joly-Lobbedez; Jean-Francois Baurain; Frédéric Rolland; Arnulf Stenzl; Michel Fabbro; Marjan van Dijk; Jörg Pinkert; Thomas Schmelter; Natasja de Bont; Patricia Pautier
Journal:  Oncologist       Date:  2013-10-08

8.  Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.

Authors:  Dawn L Hershman; Joseph M Unger; Katherine D Crew; Lori M Minasian; Danielle Awad; Carol M Moinpour; Lisa Hansen; Danika L Lew; Heather Greenlee; Louis Fehrenbacher; James L Wade; Siu-Fun Wong; Gabriel N Hortobagyi; Frank L Meyskens; Kathy S Albain
Journal:  J Clin Oncol       Date:  2013-06-03       Impact factor: 44.544
  8 in total
  1 in total

1.  SANIST: a rapid mass spectrometric SACI/ESI data acquisition and elaboration platform for verifying potential candidate biomarkers.

Authors:  Adriana Albini; Daniela Briga; Matteo Conti; Antonino Bruno; Daniela Farioli; Sara Canali; Ilaria Sogno; Gioacchino D'Ambrosio; Paolo Consonni; Douglas M Noonan
Journal:  Rapid Commun Mass Spectrom       Date:  2015-10-15       Impact factor: 2.419
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.